Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulsed vs Continuous Itraconazole for Onychomycosis
NCT05567484Phase 1Completed
- Sponsor
- Combined Military Hospital Abbottabad
- Start
- May 2021
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised trial of itraconazole in onychomycosis (2 arms), sponsored by Combined Military Hospital Abbottabad. Primary endpoint: Onychomycosis Severity Index at 12 weeks. Started May 2021; status: completed.
02
Drugs
itraconazole
03
Conditions
onychomycosis
Beyond the preview
Go deeper on NCT05567484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05567484.